What should be prioritized as the first line treatment for preventing anxiety attacks in GAD?

In the management of Generalized Anxiety Disorder (GAD), selective serotonin reuptake inhibitors (SSRIs) are recognized as the first-line treatment for preventing anxiety attacks. The efficacy of SSRIs in increasing serotonin levels in the brain helps to stabilize mood and reduce anxiety symptoms over time. They are generally well-tolerated and have a favorable safety profile compared to other medications, making them suitable for long-term management.

SSRIs are preferred because they not only help in decreasing panic attacks but also address the broader symptoms of anxiety associated with GAD. While benzodiazepines can provide rapid relief of acute anxiety symptoms, they are not recommended as a first-line treatment for long-term management due to risks of dependence and withdrawal. Similarly, monoamine oxidase inhibitors (MAOIs) are less commonly used due to dietary restrictions and potential side effects. Cognitive Behavioral Therapy (CBT) is also highly effective and can be part of a comprehensive treatment approach, but pharmacotherapy is often initiated to provide quicker symptom relief, thus positioning SSRIs as the primary treatment option.